
Protecting Patients With Blood Cancers From COVID-19
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the...
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....